PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2020 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial
Results (Provisional) for the quarter ended June 30 2020.
Further with reference to our earlier announcement dated June 30 2020 intimating the Closure of Trading Window pursuant to the Companys Code of Conduct. for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations 2015 as
amended from time to time we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company and Material Subsidiaries of the Company till September 05 2020.
Panacea Biotec: Board Meeting Intimation for Approving The Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter Ended June 30 2020
August 25, 2020
Download PDF
Panacea Biotec